🔴 Medpace Holdings is trading 32.11% down in pre-market; no confirmed catalyst

Medpace Holdings is trading at $423.76 (-32.11%) in pre-market, with no confirmed catalyst.

• No confirmed company-specific announcement, earnings release, regulatory action, or analyst move explains the September 22, 2026 pre-market decline.
• Recent coverage focuses on valuation ahead of upcoming earnings; shares were previously at $624.20.
• Insider selling totaled $15.36 million on September 15–16, but does not clearly explain this morning’s move. Confidence remains low pending clarification.